Monthly Archives: December 2012

Drug Patent Expirations for December 2012

Tradename Applicant Generic Name Patent Number Patent Expiration
NUTROPIN DEPOT Genentech somatropin recombinant 6,051,259 Dec 2, 2012
ATACAND HCT Astrazeneca candesartan cilexetil; hydrochlorothiazide 5,196,444*PED Dec 4, 2012
ATACAND Astrazeneca candesartan cilexetil 5,196,444*PED Dec 4, 2012
PAXIL CR Glaxosmithkline paroxetine hydrochloride 5,422,123*PED Dec 6, 2012
COMBIPATCH Novartis estradiol; norethindrone acetate 5,958,446 Dec 12, 2012
MUSE Meda Pharms alprostadil 5,474,535 Dec 12, 2012
PROHANCE Bracco gadoteridol 5,474,756 Dec 12, 2012
PROHANCE MULTIPACK Bracco gadoteridol 5,474,756 Dec 12, 2012
DAYTRANA Noven Pharms Inc methylphenidate 5,958,446 Dec 12, 2012
VIVELLE-DOT Novartis estradiol 5,958,446 Dec 12, 2012
COMBIPATCH Novartis estradiol; norethindrone acetate 5,474,783 Dec 12, 2012
PROHANCE Bracco gadoteridol 6,143,274 Dec 12, 2012
PROHANCE MULTIPACK Bracco gadoteridol 6,143,274 Dec 12, 2012
VIVELLE-DOT Novartis estradiol 5,474,783 Dec 12, 2012
ALPHAGAN P Allergan brimonidine tartrate 5,424,078*PED Dec 13, 2012
SYMBICORT Astrazeneca budesonide; formoterol fumarate dihydrate 5,972,919 Dec 17, 2012
TASMAR Valeant Pharms Llc tolcapone 5,476,875 Dec 19, 2012
ASMANEX TWISTHALER Schering mometasone furoate 5,394,868*PED Dec 25, 2012
SPIRIVA Boehringer Ingelheim tiotropium bromide monohydrate 5,478,578 Dec 26, 2012
MAXALT-MLT Merck rizatriptan benzoate 5,298,520*PED Dec 29, 2012
MAXALT Merck rizatriptan benzoate 5,298,520*PED Dec 29, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.